United States Federal Circuit

ResetAA Font size: Print

Vanda Pharmaceuticals Inc. v. West Ward Pharmaceuticals, 16-2707

Affirming the decision of the district court holding, after a bench trial, that the asserted claims of a patent relating to the treatment of schizophrenia with iloperidone administered based on the genotype of the patient were infringed and not invalid.

Appellate Information

  • Argued
  • Submitted
  • Decided
  • Published 2018/04/13




  • United States Federal Circuit


FindLaw Career Center

    Select a Job Title

      Post a Job  |  Careers Home

    View More